ZA975755B - Useful formulations of acid addition salt drugs. - Google Patents
Useful formulations of acid addition salt drugs.Info
- Publication number
- ZA975755B ZA975755B ZA9705755A ZA975755A ZA975755B ZA 975755 B ZA975755 B ZA 975755B ZA 9705755 A ZA9705755 A ZA 9705755A ZA 975755 A ZA975755 A ZA 975755A ZA 975755 B ZA975755 B ZA 975755B
- Authority
- ZA
- South Africa
- Prior art keywords
- acid addition
- addition salt
- useful formulations
- salt drugs
- drugs
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67334196A | 1996-06-28 | 1996-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA975755B true ZA975755B (en) | 1998-02-23 |
Family
ID=24702259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9705755A ZA975755B (en) | 1996-06-28 | 1997-06-27 | Useful formulations of acid addition salt drugs. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0954327A1 (en) |
| JP (1) | JP2000516204A (en) |
| AU (1) | AU738165B2 (en) |
| CA (1) | CA2258965A1 (en) |
| IL (1) | IL127691A0 (en) |
| WO (1) | WO1998000159A1 (en) |
| ZA (1) | ZA975755B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1303671B1 (en) | 1998-07-28 | 2001-02-23 | Nicox Sa | SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM |
| HUP0303827A2 (en) * | 2000-08-28 | 2004-04-28 | Synthon B.V. | Paroxetine compositions and processes for making the same |
| JP2006028028A (en) * | 2004-07-12 | 2006-02-02 | Teikoku Medix Kk | Oral medicinal composition |
| BRPI0503734A (en) * | 2005-08-23 | 2007-04-27 | Cristalia Prod Quimicos Farm | pharmaceutical composition in ready-to-use morphine solution for injection and unit dosage form of morphine for epidural or intrathecal administration |
| US8513259B2 (en) | 2009-07-03 | 2013-08-20 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
| US8263581B2 (en) | 2009-07-03 | 2012-09-11 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
| AU2014230834B9 (en) | 2013-03-14 | 2017-08-31 | Fresenius Kabi Deutschland Gmbh | Injectable morphine formulations |
| US9248229B2 (en) | 2013-03-14 | 2016-02-02 | Becton, Dickinson France S.A.S. | Packaging system for oxygen-sensitive drugs |
| CN118021718B (en) * | 2024-04-12 | 2024-07-02 | 成都瑞尔医药科技有限公司 | Propafenone hydrochloride injection and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2000025A (en) * | 1977-05-14 | 1979-01-04 | Pfizer Ltd | Nitroimidazole formulations |
| US4536386B1 (en) * | 1981-01-26 | 1995-03-07 | Robins Co Inc A H | Method of controlling emesis caused by cisplatin in cancer chemotherapy |
| PH22107A (en) * | 1984-06-07 | 1988-06-01 | Takeda Chemical Industries Ltd | 3-pyrazolo(1,5-a)pyrdinium cephem compounds |
| US5260289A (en) * | 1992-06-12 | 1993-11-09 | Vitacain Pharmaceutical Co., Ltd. | Composition for treating pain, method for treating pain and composition for reinforcing pain relief action |
-
1997
- 1997-06-23 JP JP10504223A patent/JP2000516204A/en active Pending
- 1997-06-23 EP EP97930184A patent/EP0954327A1/en not_active Withdrawn
- 1997-06-23 WO PCT/US1997/010829 patent/WO1998000159A1/en not_active Ceased
- 1997-06-23 CA CA002258965A patent/CA2258965A1/en not_active Abandoned
- 1997-06-23 AU AU34075/97A patent/AU738165B2/en not_active Ceased
- 1997-06-23 IL IL12769197A patent/IL127691A0/en unknown
- 1997-06-27 ZA ZA9705755A patent/ZA975755B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL127691A0 (en) | 1999-10-28 |
| CA2258965A1 (en) | 1998-01-08 |
| EP0954327A1 (en) | 1999-11-10 |
| WO1998000159A1 (en) | 1998-01-08 |
| JP2000516204A (en) | 2000-12-05 |
| AU738165B2 (en) | 2001-09-13 |
| AU3407597A (en) | 1998-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3455297A (en) | Pharmaceutical composition containing acid addition salt of basic drug | |
| PL334997A1 (en) | Derivatives or arylosulphonyl-hydroxamic acid | |
| ZA965866B (en) | 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
| ZA9610650B (en) | 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
| GB9713149D0 (en) | Pharmaceutical formulations | |
| SG79255A1 (en) | Pharmaceutical formulations | |
| ZA967745B (en) | Pharmaceutical formulations. | |
| IL135177A0 (en) | Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same | |
| HUP0100059A3 (en) | Novel pyridazine derivatives and drugs containing the same as the active ingredient | |
| HU9801044D0 (en) | Sulfonyl-amino-carboxylic acid derivatives | |
| IL130334A0 (en) | Pharmaceutical aminophosphonic acid derivatives | |
| HU9502520D0 (en) | Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives | |
| HUP0000777A3 (en) | Resolution of ritalinic acid salt | |
| HUP0102369A3 (en) | Amino acid derivatives and drugs containing the same as the active ingredient | |
| PL340461A1 (en) | Derivatives of isothiazocarboxylic acid | |
| AU5761998A (en) | Pharmaceutical aminophosphonic acid derivatives | |
| IL136612A (en) | Phenylaminoalkyl-carboxylic acid derivatives and pharmaceutical compositions containing the same | |
| ZA975755B (en) | Useful formulations of acid addition salt drugs. | |
| HUP0000084A3 (en) | 3-alkoxyisoxazol-4-yl-substituted-2-amino carboxylic acid derivatives, their use and pharmaceutical compositions containing them | |
| HUP9902458A3 (en) | Slow-release pharmaceutical formulations containing mizolastin | |
| SI0906101T1 (en) | Slow-release pharmaceutical formulations containing mizolastin | |
| GB9703607D0 (en) | Pharmaceutical formulations | |
| GB9621531D0 (en) | Pharmaceutical formulations | |
| GB9606372D0 (en) | Pharmaceutical formulations | |
| ITRM970049A0 (en) | PROCEDURE FOR THE PREPARATION OF 2-IODOXYBENZOIC ACID. |